Medical Device CRO Market Industry Trends and Global Forecasts to 2035

The global medical device CRO market is estimated to grow from USD 13.3 billion in the current year to USD 19.3 billion by 2035, at a CAGR of 3.4% during the forecast period, till 2035.

Medical Device CRO Market: Growth and Trends

The increase in geriatric population and disease incidences, primarily chronic diseases, has led to a surge in the demand for novel medical devices across multiple therapeutic areas. Since 2020, the USFDA has approved ~105 medical devices. Further, it is interesting to note that over 35 medical devices receive FDA approval annually. However, one of the primary challenges faced by this industry is the time-consuming and complex product development lifecycle of a new medical device. Specifically, the clinical stage is exceedingly resource intensive, pertaining to higher costs and greater risks. In addition, the stringent regulatory guidelines to ensure the safety of medical devices make it more difficult for industrial leaders.

In order to address the abovementioned bottleneck, medical device developers are actively outsourcing their research operations to specialized medical device CRO. These organizations offer expertise in conducting clinical trials, navigating regulatory requirements, and ensuring compliance with safety standards. By partnering closely with manufacturers, CROs support translating novel ideas into market-ready products while rigorously monitoring throughout the product development lifecycle. In addition to this, the landscape of medical devices is rapidly changing, driven by the integration of advanced technologies and tools, including risk monitoring tools, advanced data analytics, real world evidence solutions and cloud computing. Owing to the ongoing research and development, and increasing opportunities linked to the medical devices market, it is anticipated that the medical devices CRO market will witness healthy growth in the coming decade.

Medical Device CRO Market: Key Insights

The report delves into the current state of the medical device CRO market and identifies potential growth opportunities within the industry. Some key findings from the report include:

More than 590 CROs currently claim to have the required capabilities to offer a wide range of research and analytical services for medical devices, across different scale of operations.

The market is well fragmented, featuring a mix of players based across different geographical regions that provide services for a range of medical device classes.
In pursuit of building a competitive edge, medical devices CROs are actively upgrading / expanding their capabilities to enhance their respective portfolios of offerings.
Over the years, industry players have undertaken a variety of initiatives to further advance the development / enable the improvement of their proprietary services for medical devices.
The rising interest in this domain is reflected in the number of mergers and acquisitions that have been reported in the last few years; 53% of such initiatives were focused on geographical consolidation.
Over 14,000 trials, enrolling close to 4.6 million patients suffering from a myriad of disease indications, have been registered across the globe to evaluate the efficacy and accuracy of medical devices.
Our proprietary total cost of ownership model suggests an informed estimate of direct and indirect expenses while setting up a contract research facility in different regions over a span of 20 years.
Driven by the ongoing efforts of industry stakeholders, the medical devices contract research service providers the market is expected to witness steady growth in the coming decade.

Medical Device CRO Market: Key Segments

Currently, Clinical Operations Segment Occupies the Largest Share of the Medical Device CRO Market

Based on the scale of operation, the market is segmented into clinical and preclinical services. At present, the clinical services segment holds the maximum share of the medical device CRO market. It is worth highlighting that the increasing number of medical device-focused clinical trials is likely to drive the market in the near future.

Class II Devices Segment is the Fastest Growing Segment of the Medical Device CRO Market During the Forecast Period

Based on the device class, the market is segmented into Class I, Class II, Class III. Currently, class II devices hold maximum share within the medical devices CRO market. This trend is unlikely to change in the short-mid-term.

Currently, Clinical Trial Management Segment Occupies the Largest Share of the Medical Device CRO Market

Based on the type of clinical services, the market is segmented into clinical trial management, data management, regulatory affairs management, and consulting. At present, clinical trial management holds the maximum share of the medical devices CRO market. This trend is likely to remain the same in the forthcoming years.

Biocompatibility Testing Services Segment is the Fastest Growing Segment of the Medical Device CRO Market During the Forecast Period

Based on the type of preclinical services, the market is segmented into biocompatibility testing, sterility, microbiology testing, material characterization, and analytical services. It is worth highlighting that, at present, sterility and microbial testing holds a larger share of the medical device CRO market. This trend is likely to remain the same in the coming decade.

Currently, CNS Disorders Segment Occupies the Largest Share of the Medical Device CRO Market

Based on the therapeutic area, the market is segmented into cardiovascular disorders, CNS disorders, metabolic disorders, oncological disorders, ophthalmological disorders, orthopedic disorders, pain disorders, psychological disorders, respiratory disorders and other disorders. It is worth highlighting that majority of the current medical device CRO market is captured by CNS disorders.

North America Accounts for the Largest Share of the Market

Based on the key geographical regions, the market is segmented into North America, Europe, Asia-Pacific and the Rest of the world. Majority share is expected to be captured by CROs based in North America. It is worth highlighting that, over the years, the market of the rest of the world is expected to grow at a higher CAGR.

Sample Players in the Medical Device CRO Market Profiled in the Report:

Avania
Charles River Laboratories
CROMSOURCE
CSSi LifeSciences
Eurofins Medical Testing
IQVIA
Medpace
NAMSA
Qserve Group
WuXi AppTec

Primary Research Overview

The opinions and insights presented in this study were influenced by discussions conducted with multiple stakeholders. The research report features detailed transcripts of interviews held with the following industry stakeholders:

Chief Executive Officer and Co-founder, HungaroTrial
Senior Vice President of Business Development and Marketing, ClinChoice
Vice President of Global Marketing and Commercial Operations, NAMSA
Head of Business Development, CTC North
General Manager, CW Research & Management
Chief Operating Officer, CROMSOURCE
Senior manager, Medical & Clinical Operations, Metrics Research
Technical Director and Partner, Vyomus Consulting
Director of Business Development, A+ Science
Business Development Manager, AtoZ-CRO

Medical Device CRO Market: Research Coverage

Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the medical device CRO market, focusing on key market segments, including [A] scale of operation, [B] device class, [C] type of clinical services offered, [D] type of preclinical services offered, [E] therapeutic area and [F] geographical regions.
Market Landscape: A comprehensive evaluation of contract research organizations involved in the medical device CRO market, considering various parameters, such as [A] year of establishment, [B] company size (in terms of the number of employees), [C] location of headquarters, [D] area of specialization, [E] device class, [F] types of CRO services offered by [F1] clinical service providers, [F2] preclinical service providers and [F3] stand-alone service providers.
Regulatory and Reimbursement Landscape Analysis: A discussion on general regulatory guidelines established and issued by major regulatory bodies for medical device approval. In addition, it includes an insightful multi-dimensional heat map analysis, featuring a comparison of the contemporary regulatory and reimbursement scenarios in key geographies across the globe.
Company Profiles: In-depth profiles of key industry players offering CRO services for both clinical and preclinical stage development of medical devices, focusing on [A] company overviews, [B] medical device-focused service portfolio, [C] recent developments and [D] an informed future outlook.
Competitive Benchmarking Analysis: A competitive benchmarking analysis that emphasizes the primary focus areas of small, mid-sized, and large companies. This analysis compares their existing capabilities within and beyond their respective peer groups based in North America, Europe, Asia-Pacific, and other regions. It offers stakeholders insights into potential strategies for achieving a competitive edge in the industry.
Key Performance Indicators: An analysis highlighting the key performance indicators used by sponsor companies to evaluate service providers engaged in the medical device CRO market, based on information gathered via secondary research (for top-ten medical device players) and primary research.
Brand Positioning Analysis: A comprehensive analysis of brand positioning for top industry players, highlighting the prevailing perceptions of their proprietary brands.
Clinical Trials Analysis: Examination of completed, ongoing, and planned clinical studies of various medical devices, based on parameters like [A] trial registration year, [B] trial phase, [C] current trial status, [D] enrolled patient population, [E] study design, [F] leading industry players (in terms of number of trials conducted), [G] target therapeutic area(s) and [H] key geographical regions.
Merger and Acquisitions: A comprehensive examination of the various mergers and acquisitions, focusing on multiple relevant parameters, including [A] year of agreement, [B] type of agreement and [C] geographical location of the companies.
Total Cost of Ownership: An in-depth analysis of the total cost of ownership for a medical device contract research service provider, which includes a well-informed estimate of both direct and indirect costs.
Survey Analysis: A survey analysis featuring inputs solicited from various experts who are directly / indirectly involved in providing CRO services to medical device developers.
SWOT Analysis: A SWOT analysis, focusing on key drivers and challenges that are likely to impact the industry’s evolution. Further, it includes a Harvey ball analysis, highlighting the relative effect of each SWOT parameter on the overall industry.

Key Questions Answered in this Report

How many companies are currently engaged in this market?
Which are the leading companies in this market?
What factors are likely to influence the evolution of this market?
What is the current and future market size?
What is the CAGR of this market?
How is the current and future market opportunity likely to be distributed across key market segments?

Reasons to Buy this Report

The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

Additional Benefits

Complimentary PPT Insights Packs
Complimentary Excel Data Packs for all Analytical Modules in the Report
10% Free Content Customization
Detailed Report Walkthrough Session with Research Team
Free Updated report if the report is 6-12 months old or older

1. PREFACE

1.1. Scope of the Report
1.2. Market Segmentation
1.3. Research Methodology
1.4. Key Questions Answered
1.5. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

3.1. Chapter Overview
3.2. Overview of Medical Devices
3.2.1. Historical Evolution of Medical Devices
3.2.2. Classification of Medical Devices
3.3. Overview of Contract Research Organizations (CROs)
3.3.1. Evolution of CROs
3.4. Role of CROs in the Medical Device Industry

3.5. Types of Medical Device CROs
3.6. Types of Services Offered by CROs
3.7. Advantages of Outsourcing Operations to CROs
3.8. Risks and Challenges Associated with Outsourcing
3.9. Key Considerations WhileSelecting a Suitable CRO Partner

4. MARKET LANDSCAPE

4.1. Chapter Overview
4.2. Medical Device CROs: Clinical Service Providers
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Company Size and Location of Headquarters
4.2.5. Analysis by Area of Specialization
4.2.6. Analysis by Device Class
4.2.7. Analysis by Type of Clinical Operation Service Offered
4.2.8. Analysis by Type of Regulatory Affairs-related Service Offered
4.2.9. Analysis by Type of Additional Service Offered
4.2.10. Analysis by Medical Device Regulatory Compliance Authority

4.3. Medical Device CROs: Preclinical Service Providers
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Company Size
4.3.3. Analysis by Location of Headquarters
4.3.4. Analysis by Company Size and Location of Headquarters
4.3.5. Analysis by Type of Preclinical Service Offered

4.4. Medical Device CROs: Standalone Service Providers
4.4.1. Analysis by Year of Establishment
4.4.2. Analysis by Company Size
4.4.3. Analysis by Location of Headquarters
4.4.4. Analysis by Company Size and Location of Headquarters

5. REGULATORY AND REIMBURSEMENT LANDSCAPE FOR MEDICAL DEVICES

5.1. Chapter Overview
5.2. General Regulatory and Reimbursement Guidelines for Medical Devices

5.3. Regulatory and Reimbursement Landscape in North America
5.3.1. The US Scenario
5.3.1.1. Regulatory Authority
5.3.1.2. Review / Approval Process
5.3.1.3. Reimbursement Landscape
5.3.1.3.1. Payer Mix
5.3.1.3.2. Reimbursement Process

5.3.2. The Canadian Scenario
5.3.2.1. Regulatory Authority
5.3.2.2. Review / Approval Process
5.3.2.3. Reimbursement Landscape
5.3.2.3.1. Payer Mix
5.3.2.3.2. Reimbursement Process

5.3.3. The Mexican Scenario
5.3.3.1. Regulatory Authority
5.3.3.2. Review / Approval Process
5.3.3.3. Reimbursement Landscape
5.3.3.3.1. Payer Mix

5.4. Regulatory and Reimbursement Landscape in Europe
5.4.1. Overall Scenario
5.4.1.1. Overview of Regulatory Authorities
5.4.1.2. Overall Review / Approval Process

5.4.2. The UK Scenario
5.4.2.1. Regulatory Authority
5.4.2.2. Review / Approval Process
5.4.2.3. Reimbursement Landscape
5.4.2.3.1. Payer Mix
5.4.2.3.2. Reimbursement Process

5.4.3. The French Scenario
5.4.3.1. Regulatory Authority
5.4.3.2. Review / Approval Process
5.4.3.3. Reimbursement Landscape
5.4.3.3.1. Payer Mix
5.4.3.3.2. Reimbursement Process

5.4.4. The German Scenario
5.4.4.1. Regulatory Authority
5.4.4.2. Review / Approval Process
5.4.4.3. Reimbursement Landscape
5.4.4.3.1. Payer Mix
5.4.4.3.2. Reimbursement Process

5.4.5. The Italian Scenario
5.4.5.1. Regulatory Authority
5.4.5.2. Review / Approval Process
5.4.5.3. Reimbursement Landscape
5.4.5.3.1. Payer Mix
5.4.5.3.2. Reimbursement Process

5.4.6. The Spanish Scenario
5.4.6.1. Regulatory Authority
5.4.6.2. Review / Approval Process
5.4.6.3. Reimbursement Landscape
5.4.6.3.1. Payer Mix
5.4.6.3.2. Reimbursement Process

5.5. Regulatory and Reimbursement Landscape in Asia-Pacific and Rest of the World
5.5.1. The Australian Scenario
5.5.1.1. Regulatory Authority
5.5.1.2. Review / Approval Process
5.5.1.3. Reimbursement Landscape
5.5.1.3.1. Payer Mix
5.5.1.3.2. Reimbursement Process

5.5.2. The Brazilian Scenario
5.5.2.1. Regulatory Authority
5.5.2.2. Review / Approval Process
5.5.2.3. Reimbursement Landscape
5.5.2.3.1. Payer Mix
5.5.2.3.2. Reimbursement Process

5.5.3. The Chinese Scenario
5.5.3.1. Regulatory Authority
5.5.3.2. Review / Approval Process
5.5.3.3. Reimbursement Landscape
5.5.3.3.1. Payer Mix
5.5.3.3.2. Reimbursement Process

5.5.4. The Indian Scenario
5.5.4.1. Regulatory Authority
5.5.4.2. Review / Approval Process
5.5.4.3. Reimbursement Landscape
5.5.4.3.1. Payer Mix

5.5.5. The Israeli Scenario
5.5.5.1. Regulatory Authority
5.5.5.2. Review / Approval Process
5.5.5.3. Reimbursement Landscape
5.5.5.3.1. Payer Mix

5.5.6. The Japanese Scenario
5.5.6.1. Regulatory Authority
5.5.6.2. Review / Approval Process
5.5.6.3. Reimbursement Landscape
5.5.6.3.1. Payer Mix
5.5.6.3.2. Reimbursement Process

5.5.7. The New Zealand Scenario
5.5.7.1. Regulatory Authority
5.5.7.2. Review / Approval Process
5.5.7.3. Reimbursement Landscape
5.5.7.3.1. Payer Mix
5.5.7.3.2. Reimbursement Process

5.5.8. The Singapore Scenario
5.5.8.1. Regulatory Authority
5.5.8.2. Review / Approval Process
5.5.8.3. Reimbursement Landscape
5.5.8.3.1. Payer Mix
5.5.8.3.2. Reimbursement Process

5.5.9. The South Korean Scenario
5.5.9.1. Regulatory Authority
5.5.9.2. Review / Approval Process
5.5.9.3. Reimbursement Landscape
5.5.9.3.1. Payer Mix
5.5.9.3.2. Reimbursement Process

5.5.10. The South African Scenario
5.5.10.1. Regulatory Authority
5.5.10.2. Review / Approval Process
5.5.10.3. Reimbursement Landscape

5.5.11. The Taiwan Scenario
5.5.11.1. Regulatory Authority
5.5.11.2. Review / Approval Process
5.5.11.3. Reimbursement Landscape
5.5.11.3.1. Payer Mix
5.5.11.3.2. Reimbursement Process

5.5.12. The Thailand Scenario
5.5.12.1. Regulatory Authority
5.5.12.2. Review / Approval Process
5.5.12.3. Reimbursement Landscape

5.6. Comparison of Regional Regulatory Control
5.7. Concluding Remarks

6. COMPANY PROFILES

6.1. Chapter Overview

6.2. Avania (Formerly known as Factory CRO)
6.2.1. Company Overview
6.2.2. Service Portfolio
6.2.3. Recent Developments and Future Outlook

6.3. Charles River Laboratories
6.3.1. Company Overview
6.3.2. Service Portfolio
6.3.3. Recent Developments and Future Outlook

6.4. CROMSOURCE
6.4.1. Company Overview
6.4.2. Service Portfolio
6.4.3. Recent Developments and Future Outlook

6.5. CSSi LifeSciences
6.5.1. Company Overview
6.5.2. Service Portfolio
6.5.3. Recent Developments and Future Outlook

6.6. Eurofins Medical Device Testing
6.6.1. Company Overview
6.6.2. Service Portfolio
6.6.3. Recent Developments and Future Outlook

6.7. IQVIA
6.7.1. Company Overview
6.7.2. Service Portfolio
6.7.3. Recent Developments and Future Outlook

6.8. Medpace
6.8.1. Company Overview
6.8.2. Service Portfolio
6.8.3. Recent Developments and Future Outlook

6.9. NAMSA
6.9.1. Company Overview
6.9.2. Service Portfolio
6.9.3. Recent Developments and Future Outlook

6.10. Qserve Group
6.10.1. Company Overview
6.10.2. Service Portfolio
6.10.3. Recent Developments and Future Outlook

6.11. WuXi AppTec
6.11.1. Company Overview
6.11.2. Service Portfolio
6.11.3. Recent Developments and Future Outlook

7. MEDICAL DEVICE DEVELOPER AND CRO RELATIONSHIPS: KEY VALUE DRIVERS AND PERFORMANCE INDICATORS

7.1. Chapter Overview
7.2. Definition and Importance of Key Performance Indicators (KPIs)
7.3. Key Considerations for Selection of KPIs
7.4. Types of KPIs
7.4.1. Financial Indicators
7.4.1.1. Most Important KPIs
7.4.1.1.1. Financial Stability
7.4.1.1.2. Cost of Services Offered
7.4.1.1.3. Comparative Analysis of Financial Indicators

7.4.1.2. Industry Perspective
7.4.1.2.1. Sponsors’ (Big Pharma) Perspective
7.4.1.2.2. Contract Service Providers’ Perspective

7.4.2. Process and Capability Indicators
7.4.2.1. Most Important KPIs
7.4.2.1.1. Proximity to Sponsor
7.4.2.1.2. Capability to Innovate / Mitigate Risk
7.4.2.1.3. Strength of Service Portfolio
7.4.2.1.4. Comparative Analysis of Process / Capability Indicators

7.4.2.2. Industry Perspective
7.4.2.2.1. Sponsors’ (Big Pharma) Perspective
7.4.2.2.2. Contract Service Providers’ Perspective

7.4.3. Market Reputation Indicators
7.4.3.1. Most Important KPIs
7.4.3.1.1. Flexibility / Adaptability
7.4.3.1.2. Time Management
7.4.3.1.3. Quality / Reliability
7.4.3.1.4. Regulatory Compliance / Track Record
7.4.3.1.5. Comparative Analysis of Market Reputation Indicators

7.4.3.2. Industry Perspective
7.4.3.2.1. Sponsors’ (Big Pharma) Perspective
7.4.3.2.2. Contract Service Providers’ Perspective

7.5. Comparison of Key Performance Indicators
7.6. Concluding Remarks

8. COMPETITIVE BENCHMARKING

8.1. Chapter Overview
8.2. Assumptions and Methodology
8.3. Competitive Benchmarking by Region
8.3.1. Competitive Benchmarking: Small Players based in North America (Peer Group I)
8.3.2. Competitive Benchmarking: Mid-sized Players based in North America (Peer Group II)
8.3.3. Competitive Benchmarking: Large Players based in North America (Peer Group III)
8.3.4. Competitive Benchmarking: Small Players based in Europe (Peer Group IV)
8.3.5. Competitive Benchmarking: Mid-sized Players based in Europe (Peer Group V)
8.3.6. Competitive Benchmarking: Large Players based in Europe (Peer Group VI)
8.3.7. Competitive Benchmarking: Small Players based in Asia-Pacific (Peer Group VII)
8.3.8. Competitive Benchmarking: Mid-sized Players based in Asia-Pacific (Peer Group VIII)
8.3.9. Competitive Benchmarking: Large Players based in Asia-Pacific (Peer Group IX)
8.3.10. Competitive Benchmarking: Small Players based in RoW (Peer Group X)
8.3.11. Competitive Benchmarking: Mid-sized Players based in RoW (Peer Group XI)
8.4. Concluding Remarks

9. BRAND POSITIONING OF KEY INDUSTRY PLAYERS

9.1. Chapter Overview
9.2. Scope and Methodology
9.3. Brand Positioning Matrix: Labcorp
9.4. Brand Positioning Matrix: IQVIA
9.5. Brand Positioning Matrix: Syneos Health
9.6. Brand Positioning Matrix: PPD
9.7. Brand Positioning Matrix: ICON
9.8. Brand Positioning Matrix: Charles River Laboratories
9.9. Brand Positioning Matrix: WuXi AppTec
9.10. Brand Positioning Matrix: Medpace
9.11. Brand Positioning Matrix: NAMSA

10. CLINICAL TRIAL ANALYSIS
10.1. Chapter Overview
10.2. Scope and Methodology
10.3. Medical Devices: Clinical Trial Analysis
10.3.1. Analysis by Trial Registration Year
10.3.2. Analysis by Trial Status
10.3.3. Analysis by Phase of Development
10.3.4. Analysis by Study Design
10.3.5. Analysis by Therapeutic Area
10.3.6. Analysis by Geography
10.3.7. Analysis by Trial Registration Year and Geography
10.3.8. Analysis by Trial Status and Geography
10.3.9. Analysis by Type of Sponsor
10.3.10. Most Active Players: Analysis by Number of Clinical Trials

10.4. Medical Devices: Analysis by Enrolled Patient Population
10.4.1. Analysis by Trial Registration Year
10.4.2. Analysis by Phase of Development
10.4.3. Analysis by Geography
10.4.4. Analysis by Trial Status and Geography

11. MERGERS AND ACQUISITIONS

11.1. Chapter Overview
11.2. Merger and Acquisition Models
11.3. Medical Device CROs: Mergers and Acquisitions
11.3.1. Analysis by Year of Merger / Acquisition
11.3.2. Analysis by Type of Agreement
11.3.3. Regional Analysis
11.3.3.1. Analysis by Continent
11.3.3.2. Intercontinental and Intracontinental Deals
11.3.3.3. Analysis by Country

11.3.4. Ownership Change Matrix
11.3.5. Analysis by Type of Company
11.3.6. Analysis by Key Value Drivers
11.3.6.1. Analysis by Year of Acquisition and Key Value Drivers

12. TOTAL COST OF OWNERSHIP FOR MEDICAL DEVICES CONTRACT RESEARCH ORGANIZATION

12.1. Chapter Overview
12.2. Key Parameters
12.3. Assumptions and Methodology
12.4. Sample Dataset for the estimation of Total Cost of Ownership
12.4.1. Total Cost of Ownership for Large Medical Device Contract Research Organizations, Y0-Y20
12.4.2. Total Cost of Ownership for Large Medical Device Contract Research Organizations: Analysis by CAPEX, Y0
12.4.3. Total Cost of Ownership for Large Medical Device Contract Research Organizations: Analysis by OPEX, Y1-Y20

13. SURVEY INSIGHTS

13.1. Chapter Overview
13.2. Designation of Respondents
13.3. Types of Services Offered
13.4. Target Therapeutic Area
13.5. Average Number of Annual Projects
13.6. Market Opportunity

14. MARKET SIZING AND OPPORTUNITY ANALYSIS

14.1. Chapter Overview
14.2. Assumptions and Forecast Methodology

14.3. Overall Medical Device CROs Market, till 2035
14.3.1. Medical Device CROs Market: Analysis by Therapeutic Area, 2022, 2028 and 2035
14.3.2. Medical Device CROs Market: Analysis by Scale of Operation, till 2035
14.3.3. Medical Device CROs Market: Analysis by Device Class, till 2035
14.3.4. Medical Device CROs Market, till 2035: Analysis by Type of Clinical Service Offered, till 2035
14.3.5. Medical Device CROs Market, till 2035: Analysis by Type of Preclinical Service Offered, till 2035
14.3.6. Medical Device CROs Market: Analysis by Geography, 2022, 2028 and 2035

14.4. Medical Device CROs Market in North America, till 2035
14.4.1. Medical Device CROs Market in North America: Analysis by Therapeutic Area, till 2035
14.4.1.1. Medical Device CROs Market for CNS Disorders in North America, till 2035
14.4.1.2. Medical Device CROs Market for Cardiovascular Disorders in North America, till 2035
14.4.1.3. Medical Device CROs Market for Oncological Disorders in North America, till 2035
14.4.1.4. Medical Device CROs Market for Bone Disorders in North America, till 2035
14.4.1.5. Medical Device CROs Market for Respiratory Disorders in North America, till 2035
14.4.1.6. Medical Device CROs Market for Pain Management Disorders in North America, till 2035
14.4.1.7. Medical Device CROs Market for Ophthalmic Disorders in North America, till 2035
14.4.1.8. Medical Device CROs Market for Psychological Disorders in North America, till 2035
14.4.1.9. Medical Device CROs Market for Metabolic Disorders in North America, till 2035
14.4.1.10.Medical Device CROs Market for Other Disorders in North America, till 2035

14.4.2. Medical Device CROs Market in North America: Analysis by Device Class, till 2035
14.4.2.1. Medical Device CROs Market for Class I Devices in North America, till 2035
14.4.2.2. Medical Device CROs Market for Class II Devices in North America, till 2035
14.4.2.3. Medical Device CROs Market for Class III Devices in North America, till 2035

14.4.3. Medical Device CROs Market in North America: Analysis by Type of Clinical Service Offered, till 2035
14.4.3.1. Medical Device CROs Market for Clinical Trial Management Services in North America, till 2035
14.4.3.2. Medical Device CROs Market for Consulting Services in North America, till 2035
14.4.3.3. Medical Device CROs Market for Data Management Services in North America, till 2035
14.4.3.4. Medical Device CROs Market for Regulatory Affairs Management Services in North America, till 2035
14.4.3.5. Medical Device CROs Market for Other Clinical Services in North America, till 2035

14.4.4. Medical Device CROs Market in North America: Analysis by Type of Preclinical Service Offered, till 2035
14.4.4.1. Medical Device CROs Market for Material Characterization and Analytical Services in North America, till 2035
14.4.4.2. Medical Device CROs Market for Biocompatibility Testing Services in North America, till 2035
14.4.4.3. Medical Device CROs Market for Sterility and Microbiology Testing Services in North America, till 2035
14.4.4.4. Medical Device CROs Market for Other Preclinical Services in North America, till 2035

14.5. Medical Device CROs Market in Europe, till 2035
14.5.1. Medical Device CROs Market in Europe: Analysis by Therapeutic Area, till 2035
14.5.1.1. Medical Device CROs Market for CNS Disorders in Europe, till 2035
14.5.1.2. Medical Device CROs Market for Cardiovascular Disorders in Europe, till 2035
14.5.1.3. Medical Device CROs Market for Oncological Disorders in Europe, till 2035
14.5.1.4. Medical Device CROs Market for Bone Disorders in Europe, till 2035
14.5.1.5. Medical Device CROs Market for Respiratory Disorders in Europe, till 2035
14.5.1.6. Medical Device CROs Market for Pain Management Disorders in Europe, till 2035
14.5.1.7. Medical Device CROs Market for Ophthalmic Disorders in Europe, till 2035
14.5.1.8. Medical Device CROs Market for Psychological Disorders in Europe, till 2035
14.5.1.9. Medical Device CROs Market for Metabolic Disorders in Europe, till 2035
14.5.1.10.Medical Device CROs Market for Other Disorders in Europe, till 2035

14.5.2. Medical Device CROs Market in Europe: Analysis by Device Class, till 2035
14.5.2.1. Medical Device CROs Market for Class I Devices in Europe, till 2035
14.5.2.2. Medical Device CROs Market for Class II Devices in Europe, till 2035
14.5.2.3. Medical Device CROs Market for Class III Devices in Europe, till 2035

14.5.3. Medical Device CROs Market in Europe: Analysis by Type of Clinical Service Offered, till 2035
14.5.3.1. Medical Device CROs Market for Clinical Trial Management Services in Europe, till 2035
14.5.3.2. Medical Device CROs Market for Consulting Services in Europe, till 2035
14.5.3.3. Medical Device CROs Market for Data Management Services in Europe, till 2035
14.5.3.4. Medical Device CROs Market for Regulatory Affairs Management Services in Europe, till 2035
14.5.3.5. Medical Device CROs Market for Other Clinical Services in Europe, till 2035
14.5.4. Medical Device CROs Market in Europe: Analysis by Type of Preclinical Service Offered, till 2035
14.5.4.1. Medical Device CROs Market for Material Characterization and Analytical Services in Europe, till 2035
14.5.4.2. Medical Device CROs Market for Biocompatibility Testing Services in Europe, till 2035
14.5.4.3. Medical Device CROs Market for Sterility and Microbiology Testing Services in Europe, till 2035
14.5.4.4. Medical Device CROs Market for Other Preclinical Services in Europe, till 2035

14.6. Medical Device CROs Market in Asia-Pacific, till 2035
14.6.1. Medical Device CROs Market in Asia-Pacific: Analysis by Therapeutic Area, till 2035
14.6.1.1. Medical Device CROs Market for CNS Disorders in Asia-Pacific, till 2035
14.6.1.2. Medical Device CROs Market for Cardiovascular Disorders in Asia-Pacific, till 2035
14.6.1.3. Medical Device CROs Market for Oncological Disorders in Asia-Pacific, till 2035
14.6.1.4. Medical Device CROs Market for Bone Disorders in Asia-Pacific, till 2035
14.6.1.5. Medical Device CROs Market for Respiratory Disorders in Asia-Pacific, till 2035
14.6.1.6. Medical Device CROs Market for Pain Management Disorders in Asia-Pacific, till 2035
14.6.1.7. Medical Device CROs Market for Ophthalmic Disorders in Asia-Pacific, till 2035
14.6.1.8. Medical Device CROs Market for Psychological Disorders in Asia-Pacific, till 2035
14.6.1.9. Medical Device CROs Market for Metabolic Disorders in Asia-Pacific, till 2035
14.6.1.10.Medical Device CROs Market for Other Disorders in Asia-Pacific, till 2035

14.6.2. Medical Device CROs Market in Asia-Pacific: Analysis by Device Class, till 2035
14.6.2.1. Medical Device CROs Market for Class I Devices in Asia-Pacific, till 2035
14.6.2.2. Medical Device CROs Market for Class II Devices in Asia-Pacific, till 2035
14.6.2.3. Medical Device CROs Market for Class III Devices in Asia-Pacific, till 2035

14.6.3. Medical Device CROs Market in Asia-Pacific: Analysis by Type of Clinical Service Offered, till 2035
14.6.3.1. Medical Device CROs Market for Clinical Trial Management Services in Asia-Pacific, till 2035
14.6.3.2. Medical Device CROs Market for Consulting Services in Asia-Pacific, till 2035
14.6.3.3. Medical Device CROs Market for Data Management Services in Asia-Pacific, till 2035
14.6.3.4. Medical Device CROs Market for Regulatory Affairs Management Services in Asia-Pacific, till 2035
14.6.3.5. Medical Device CROs Market for Other Clinical Services in Asia-Pacific, till 2035

14.6.4. Medical Device CROs Market in Asia-Pacific: Analysis by Type of Preclinical Service Offered, till 2035
14.6.4.1. Medical Device CROs Market for Material Characterization and Analytical Services in Asia-Pacific, till 2035
14.6.4.2. Medical Device CROs Market for Biocompatibility Testing Services in Asia-Pacific, till 2035
14.6.4.3. Medical Device CROs Market for Sterility and Microbiology Testing Services in Asia-Pacific, till 2035
14.6.4.4. Medical Device CROs Market for Other Preclinical Services in Asia-Pacific, till 2035

14.7. Medical Device CROs Market in Rest of the World, till 2035
14.7.1. Medical Device CROs Market in Rest of the World: Analysis by Therapeutic Area, till 2035
14.7.1.1. Medical Device CROs Market for CNS Disorders in Rest of the World, till 2035
14.7.1.2. Medical Device CROs Market for Cardiovascular Disorders in Rest of the World, till 2035
14.7.1.3. Medical Device CROs Market for Oncological Disorders in Rest of the World, till 2035
14.7.1.4. Medical Device CROs Market for Bone Disorders in Rest of the World, till 2035
14.7.1.5. Medical Device CROs Market for Respiratory Disorders in Rest of the World, till 2035
14.7.1.6. Medical Device CROs Market for Pain Management Disorders in Rest of the World, till 2035
14.7.1.7. Medical Device CROs Market for Ophthalmic Disorders in Rest of the World, till 2035
14.7.1.8. Medical Device CROs Market for Psychological Disorders in Rest of the World, till 2035
14.7.1.9. Medical Device CROs Market for Metabolic Disorders in Rest of the World, till 2035
14.7.1.10.Medical Device CROs Market for Other Disorders in Rest of the World, till 2035

14.7.2. Medical Device CROs Market in Rest of the World: Analysis by Device Class, till 2035
14.7.2.1. Medical Device CROs Market for Class I Devices in Rest of the World, till 2035
14.7.2.2. Medical Device CROs Market for Class II Devices in Rest of the World, till 2035
14.7.2.3. Medical Device CROs Market for Class III Devices in Rest of the World, till 2035

4.7.3. Medical Device CROs Market in Rest of the World: Analysis by Type of Clinical Service Offered, till 2035
14.7.3.1. Medical Device CROs Market for Clinical Trial Management Services in Rest of the World, till 2035
14.7.3.2. Medical Device CROs Market for Consulting Services in Rest of the World, till 2035
14.7.3.3. Medical Device CROs Market for Data Management Services in Rest of the World, till 2035
14.7.3.4. Medical Device CROs Market for Regulatory Affairs Management Services in Rest of the World, till 2035
14.7.3.5. Medical Device CROs Market for Other Clinical Services in Rest of the World, till 2035

14.7.4. Medical Device CROs Market in Rest of the World: Analysis by Type of Preclinical Service Offered, till 2035
14.7.4.1. Medical Device CROs Market for Material Characterization and Analytical Services in Rest of the World, till 2035
14.7.4.2. Medical Device CROs Market for Biocompatibility Testing Services in Rest of the World, till 2035
14.7.4.3. Medical Device CROs Market for Sterility and Microbiology Testing Services in Rest of the World, till 2035
14.7.4.4. Medical Device CROs Market for Other Preclinical Services in Rest of the World, till 2035

15. SWOT ANALYSIS

15.1. Chapter Overview
15.2. Strengths
15.3. Weaknesses
15.4. Opportunities
15.5. Threats
15.6. Concluding Remarks

16. FUTURE TRENDS AND OPPORTUNITIES

16.1. Chapter Overview
16.2. Anticipated Growth in Number of Connected Devices
16.3. Adoption of Data Analytics and Real-Time Monitoring Solutions
16.4. Need for Cloud-based Computing and Storage Solutions
16.5. Growing Demand for Real World Evidence to Obtain Regulatory Approval
16.6. Concluding Remarks

17. CONCLUDING REMARKS

18. INTERVIEW TRANSCRIPTS

18.1. Chapter Overview
18.2. HungaroTrial
18.2.1. Company Snapshot
18.2.2. Interview Transcript: Lajos Sarosi, Chief Executive Officer and Co-founder
18.3. ClinChoice
18.3.1. Company Snapshot
18.3.2. Lee King, Senior Vice President of Business Development and Marketing
18.4. NAMSA
18.4.1. Company Snapshot
18.4.2. Christopher Rupp, Vice President of Global Marketing and Commercial Operations
18.5. CTC North
18.5.1. Company Snapshot
18.5.2. Claus Hemiker, Head of Business Development
18.6. CW Research & Management
18.6.1. Company Snapshot
18.6.2. Christian Wolflehner, General Manager
18.7. CROMSOURCE
18.7.1. Company Snapshot
18.7.2. Troy McCall, Chief Operating Officer
18.8. Metrics Research
18.8.1. Company Snapshot
18.8.2. Nazish Urooj, Senior manager, Medical & Clinical Operations
18.9. Vyomus Consulting
18.9.1. Company Snapshot
18.9.2. C. Omprakash, Technical Director and Partner
18.10. A+ Science
18.10.1. Company Snapshot
18.10.2. Tania Persson, Director of Business Development
18.11. AtoZ-CRO
18.11.1 Company Snapshot
18.11.2. Alexa Foltin-Mertgen, Business Development Manager

19. APPENDIX 1: TABULATED DATA20. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

LIST OF FIGURES

Figure 2.1 Executive Summary: Overall Market Landscape
Figure 2.2 Executive Summary: Clinical Trial Analysis
Figure 2.3 Executive Summary: Mergers and Acquisitions
Figure 2.4 Executive Summary: Total Cost of Ownership
Figure 2.5 Executive Summary: Market Sizing and Opportunity Analysis (1/2)
Figure 2.6 Executive Summary: Market Sizing and Opportunity Analysis (2/2)
Figure 3.1 Historical Timeline of Medical Device Inventions
Figure 3.2 Medical Device: Development Process and Timeline
Figure 3.3 Types of CROs Engaged in the Medical Device Market
Figure 3.4 Services Offered by CROs
Figure 3.5 Risks / Challenges Associated with Outsourcing Operations to CROs
Figure 4.1 Medical Device Clinical CROs: Distribution by Year of Establishment
Figure 4.2 Medical Device Clinical CROs: Distribution by Company Size
Figure 4.3 Medical Device Clinical CROs: Distribution by Location of Headquarters
Figure 4.4 Medical Device Clinical CROs: Distribution by Company Size and Location of Headquarters
Figure 4.5 Medical Device Clinical CROs: Distribution by Area of Specialization
Figure 4.6 Medical Device Clinical CROs: Distribution by Device Class
Figure 4.7 Medical Device Clinical CROs: Distribution by Type of Clinical Operation Service Offered
Figure 4.8 Medical Device Clinical CROs: Distribution by Year of Establishment, Type of Clinical Service Offered and Geography
Figure 4.9 Medical Device Clinical CROs: Distribution by Type of Regulatory Affairs-related Service Offered
Figure 4.10 Medical Device Clinical CROs: Distribution by Type of Additional Service Offered
Figure 4.11 Medical Device Clinical CROs: Distribution by Type of Medical Device Regulatory Compliance Authority
Figure 4.12 Medical Device Preclinical CROs: Distribution by Year of Establishment
Figure 4.13 Medical Device Preclinical CROs: Distribution by Company Size
Figure 4.14 Medical Device Preclinical CROs: Distribution by Location of Headquarters
Figure 4.15 Medical Device Preclinical CROs: Distribution by Company Size and Location of Headquarters
Figure 4.16 Medical Device Preclinical CROs: Distribution by Type of Preclinical Service Offered
Figure 4.17 Medical Device Preclinical CROs: Distribution by Year of Establishment, Type of Preclinical Service Offered and Geography
Figure 4.18 Medical Device Standalone CROs: Distribution by Year of Establishment
Figure 4.19 Medical Device Standalone CROs: Distribution by Company Size
Figure 4.20 Medical Device Standalone CROs: Distribution by Location of Headquarters
Figure 4.21 Medical Device Standalone CROs: Distribution by Company Size and Location of Headquarters
Figure 5.1 Key Regulatory Authorities for Medical Devices
Figure 5.2 Medical Devices Review / Approval Process in the US
Figure 5.3 Healthcare Insurance Coverage in the US: Distribution by Type of Coverage
Figure 5.4 Medical Devices National Coverage Determination Process in the US
Figure 5.5 Medical Devices Review / Approval Process in Canada
Figure 5.6 Healthcare Insurance Coverage in Canada: Distribution by Type of Coverage
Figure 5.7 Medical Devices Review / Approval Process in Mexico
Figure 5.8 Regulatory Bodies in EU5 Countries
Figure 5.9 Steps involved in CE Marking Process
Figure 5.10 Medical Devices Review / Approval Process in Europe
Figure 5.11 Medical Devices Review / Approval Process in the UK
Figure 5.12 Healthcare Insurance Coverage in the UK: Distribution by Type of Coverage
Figure 5.13 Reimbursement Process for Medical Devices in the UK
Figure 5.14 Healthcare Insurance Coverage in France: Distribution by Type of Coverage
Figure 5.15 Reimbursement Process for Medical Devices through List of Products and Services Qualifying for Reimbursement
Figure 5.16 Healthcare Insurance Coverage in Germany: Distribution by Type of Coverage
Figure 5.17 Reimbursement Process for In-Patient Setting in Germany
Figure 5.18 Reimbursement Process for Out-Patient Care in Germany
Figure 5.19 Healthcare Insurance Coverage in Italy: Distribution by Type of Coverage
Figure 5.20 Reimbursement Process for Medical Devices in Italy
Figure 5.21 Healthcare Insurance Coverage in Spain: Distribution by Type of Coverage
Figure 5.22 Reimbursement Process for Medical Devices in Spain
Figure 5.23 Medical Devices Review / Approval Process in Australia
Figure 5.24 Healthcare Insurance Coverage in Australia: Distribution by Type of Coverage
Figure 5.25 Medical Devices Review / Approval Process in Brazil
Figure 5.26 Reimbursement Process for Medical Devices in Brazil
Figure 5.27 Medical Devices Review / Approval Process in China
Figure 5.28 Healthcare Insurance Coverage in China: Distribution by Type of Coverage
Figure 5.29 Reimbursement Approval Process for Medical Devices in Shanghai
Figure 5.30 Medical Devices Review / Approval Process in India
Figure 5.31 Healthcare Insurance Coverage in Israel: Distribution by Type of Coverage
Figure 5.32 Medical Devices Review / Approval Process in Japan
Figure 5.33 Snapshot of the Regulatory and Reimbursement Process in Japan
Figure 5.34 Healthcare Insurance Coverage in Japan: Distribution by Type of Coverage
Figure 5.35 Reimbursement Process for New Medical Devices in Japan
Figure 5.36 Medical Devices Review / Approval Process in New Zealand
Figure 5.37 Healthcare Insurance Coverage in New Zealand: Distribution by Type of Coverage
Figure 5.38 Medical Devices Review / Approval Process in Singapore
Figure 5.39 Medical Devices Review / Approval Process in South Korea
Figure 5.40 Healthcare Insurance Coverage in South Korea: Distribution by Type of Coverage
Figure 5.41 Medical Devices Review / Approval Process in South Africa
Figure 5.42 Medical Devices Review / Approval Process in Taiwan
Figure 5.43 Healthcare Insurance Coverage in Taiwan: Distribution by Type of Coverage
Figure 5.44 Medical Devices Review / Approval Process in Thailand
Figure 5.45 Heat Map Analysis: Comparison of Regional Regulatory Control for Medical Devices
Figure 5.46 Regulatory Control for Medical Devices: Regional Distribution by Device Risk Category
Figure 6.1 Avania: Service Portfolio
Figure 6.2 Charles River Laboratories: Service Portfolio
Figure 6.3 CROMSOURCE: Service Portfolio
Figure 6.4 CSSi LifeSciences: Service Portfolio
Figure 6.5 Eurofins Medical Device Testing: Preclinical Service Portfolio
Figure 6.6 Eurofins Medical Device Testing: Clinical Service Portfolio
Figure 6.7 IQVIA: Service Portfolio
Figure 6.8 Medpace: Service Portfolio
Figure 6.9 NAMSA: Service Portfolio
Figure 6.10 Qserve Group: Service Portfolio
Figure 6.11 WuXi AppTec: Preclinical Service Portfolio
Figure 6.12 WuXi AppTec: Clinical Service Portfolio
Figure 7.1 Key Attributes for Selection of Key Performance Indicators (KPIs)
Figure 7.2 Types of KPIs
Figure 7.3 Financial Indicators: Comparative Analysis of KPIs considered by Big Pharma Companies
Figure 7.4 Financial Indicators: Sponsors’ (Big Pharma) Perspective
Figure 7.5 Financial Indicators: Contract Service Providers’ Perspective
Figure 7.6 Process / Capability Indicators: Comparative Analysis of KPIs considered by Big Pharma Companies
Figure 7.7 Process / Capability Indicators: Sponsors’ (Big Pharma) Perspective
Figure 7.8 Process / Capability Indicators: Contract Service Providers’ Perspective
Figure 7.9 Market Reputation Indicators: Comparative Analysis of KPIs considered by Big Pharma Companies
Figure 7.10 Market Reputation Indicators: Sponsors’ (Big Pharma) Perspective
Figure 7.11 Market Reputation Indicators: Contract Service Providers’ Perspective
Figure 7.12 Comparison of Key Factors to be considered while selecting KPIs for Medical Devices
Figure 8.1 Competitive Benchmarking: Distribution by Region and Company Size
Figure 8.2 Competitive Benchmarking: Small Players based in North America (Peer Group I)
Figure 8.3 Competitive Benchmarking: Mid-sized Players based in North America (Peer Group II)
Figure 8.4 Competitive Benchmarking: Large Players based in North America (Peer Group III)
Figure 8.5 Competitive Benchmarking: Small Players based in Europe (Peer Group IV)
Figure 8.6 Competitive Benchmarking: Mid-sized Players based in Europe (Peer Group V)
Figure 8.7 Competitive Benchmarking: Large Players based in Europe (Peer Group VI)
Figure 8.8 Competitive Benchmarking: Small Players based in Asia-Pacific (Peer Group VII)
Figure 8.9 Competitive Benchmarking: Mid-sized Players based in Asia-Pacific (Peer Group VIII)
Figure 8.10 Competitive Benchmarking: Large Players based in Asia-Pacific (Peer Group IX)
Figure 8.11 Competitive Benchmarking: Small Players based in Rest of the World (Peer Group X)
Figure 8.12 Competitive Benchmarking: Mid-sized Players based in Rest of the World (Peer Group XI)
Figure 8.13 Competitive Benchmarking Summary
Figure 9.1 Brand Positioning of Key Industry Players: Unfair Advantage
Figure 9.2 Brand Positioning of Key Industry Players: Reasons to Believe
Figure 9.3 Brand Positioning Matrix: Labcorp
Figure 9.4 Brand Positioning Matrix: IQVIA
Figure 9.5 Brand Positioning Matrix: Syneos Health
Figure 9.6 Brand Positioning Matrix: PPD
Figure 9.7 Brand Positioning Matrix: ICON
Figure 9.8 Brand Positioning Matrix: Charles River Laboratories
Figure 9.9 Brand Positioning Matrix: WuXi AppTec
Figure 9.10 Brand Positioning Matrix: Medpace
Figure 10.1 Clinical Trial Analysis: Distribution by Trial Registration Year, 2015-2022
Figure 10.2 Clinical Trial Analysis: Distribution by Trial Status
Figure 10.3 Clinical Trial Analysis: Distribution by Phase of Development
Figure 10.4 Clinical Trial Analysis: Distribution by Study Design
Figure 10.5 Clinical Trial Analysis: Distribution by Therapeutic Area
Figure 10.6 Clinical Trial Analysis: Distribution by Geography
Figure 10.7 Clinical Trial Analysis: Distribution by Trial Registration Year and Geography
Figure 10.8 Clinical Trial Analysis: Distribution by Trial Status and Geography
Figure 10.9 Clinical Trial Analysis: Distribution by Type of Sponsor
Figure 10.10 Most Active Players: Distribution by Number of Clinical Trials
Figure 10.11 Clinical Trial Analysis: Distribution of Enrolled Patient Population by Trial Registration Year
Figure 10.12 Clinical Trial Analysis: Distribution of Enrolled Patient Population by Phase of Development
Figure 10.13 Clinical Trial Analysis: Distribution of Enrolled Patient Population by Geography
Figure 10.14 Clinical Trial Analysis: Distribution of Enrolled Patient Population by Trial Status and Geography
Figure 11.1 Mergers and Acquisitions: Cumulative Year-Wise Trend (since 2015)
Figure 11.2 Mergers and Acquisitions: Distribution by Type of Agreement
Figure 11.3 Mergers and Acquisitions: Distribution by Year and Type of Agreement
Figure 11.4 Mergers and Acquisitions: Continent-wise Distribution
Figure 11.5 Mergers and Acquisitions: Intercontinental and Intracontinental Acquisitions
Figure 11.6 Mergers and Acquisitions: Country-wise Distribution
Figure 11.7 Mergers and Acquisitions: Ownership Change Matrix
Figure 11.8 Mergers and Acquisitions: Distribution by Type of Company
Figure 11.9 Mergers and Acquisitions: Distribution by Key Value Drivers
Figure 11.10 Mergers and Acquisitions: Distribution by Year of Acquisition and Key Value Drivers
Figure 12.1 Total Cost of Ownership: Capital Expenditures (CAPEX)
Figure 12.2 Total Cost of Ownership: Operational Expenditures (OPEX)
Figure 12.3 Total Cost of Ownership for Large Medical Device Contract Research Organizations, Y0-Y20 (USD Million)
Figure 12.4 Total Cost of Ownership for Large Medical Device Contract Research Organizations, Y0: Distribution of CAPEX (USD Million)
Figure 12.5 Total Cost of Ownership for Large Medical Device Contract Research Organizations, Y1-Y20: Distribution by OPEX (USD Million)
Figure 13.1 Survey Insights: Distribution of Respondents by Designation and Seniority Level
Figure 13.2 Survey Insights: Distribution of Respondents by Type of Service Offered
Figure 13.3 Survey Insights: Distribution of Respondents by Therapeutic Area
Figure 13.4 Survey Insights: Distribution of Respondents by Average Number of Annual Projects
Figure 13.5 Survey Insights: Distribution of Respondents by Market Opportunity
Figure 14.1 Overall Medical Device CROs Market, till 2035 (USD Billion)
Figure 14.2 Medical Device CROs Market, 2022, 2028 and 2035: Distribution by Therapeutic Area (USD Billion)
Figure 14.3 Medical Device CROs Market, till 2035: Distribution by Scale of Operation (USD Billion)
Figure 14.4 Medical Device CROs Market, till 2035: Distribution by Device Class (USD Billion)
Figure 14.5 Medical Device CROs Market, till 2035: Distribution by Type of Clinical Service Offered (USD Billion)
Figure 14.6 Medical Device CROs Market, till 2035: Distribution by Type of Preclinical Service Offered (USD Billion)
Figure 14.7 Medical Device CROs Market, 2022, 2028 and 2035: Distribution by Geography (USD Billion)
Figure 14.8 Medical Device CROs Market in North America, till 2035 (USD Billion)
Figure 14.9 Medical Device CROs Market for CNS Disorders in North America, till 2035 (USD Billion)
Figure 14.10 Medical Device CROs Market for Cardiovascular Disorders in North America, till 2035 (USD Billion)
Figure 14.11 Medical Device CROs Market for Oncological Disorders in North America, till 2035 (USD Billion)
Figure 14.12 Medical Device CROs Market for Bone Disorders in North America, till 2035 (USD Billion)
Figure 14.13 Medical Device CROs Market for Respiratory Disorders in North America, till 2035 (USD Billion)
Figure 14.14 Medical Device CROs Market for Pain Disorders in North America, till 2035 (USD Billion)
Figure 14.15 Medical Device CROs Market for Ophthalmic Disorders in North America, till 2035 (USD Billion)
Figure 14.16 Medical Device CROs Market for Psychological Disorders in North America, till 2035 (USD Billion)
Figure 14.17 Medical Device CROs Market for Metabolic Disorders in North America, till 2035 (USD Billion)
Figure 14.18 Medical Device CROs Market for Other Disorders in North America, till 2035 (USD Billion)
Figure 14.19 Medical Device CROs Market for Class I Devices in North America, till 2035 (USD Billion)
Figure 14.20 Medical Device CROs Market for Class II Devices in North America, till 2035 (USD Billion)
Figure 14.21 Medical Device CROs Market for Class III Devices in North America, till 2035 (USD Billion)
Figure 14.22 Medical Device CROs Market for Clinical Trial Management Services in North America, till 2035 (USD Billion)
Figure 14.23 Medical Device CROs Market for Consulting Services in North America, till 2035 (USD Billion)
Figure 14.24 Medical Device CROs Market for Data Management Services in North America, till 2035 (USD Billion)
Figure 14.25 Medical Device CROs Market for Regulatory Affairs Management Services in North America, till 2035 (USD Billion)
Figure 14.26 Medical Device CROs Market for Other Clinical Services in North America, till 2035 (USD Billion)
Figure 14.27 Medical Device CROs Market for Material Characterization and Analytical Services in North America, till 2035 (USD Billion)
Figure 14.28 Medical Device CROs Market for Biocompatibility Testing Services in North America, till 2035 (USD Billion)
Figure 14.29 Medical Device CROs Market for Sterility and Microbiology Testing Services in North America, till 2035 (USD Billion)
Figure 14.30 Medical Device CROs Market for Other Preclinical Services in North America, till 2035 (USD Billion)
Figure 14.31 Medical Device CROs Market in Europe, till 2035 (USD Billion)
Figure 14.32 Medical Device CROs Market for CNS Disorders in Europe, till 2035 (USD Billion)
Figure 14.33 Medical Device CROs Market for Cardiovascular Disorders in Europe, till 2035 (USD Billion)
Figure 14.34 Medical Device CROs Market for Oncological Disorders in Europe, till 2035 (USD Billion)
Figure 14.35 Medical Device CROs Market for Bone Disorders in Europe, till 2035 (USD Billion)
Figure 14.36 Medical Device CROs Market for Respiratory Disorders in Europe, till 2035 (USD Billion)
Figure 14.37 Medical Device CROs Market for Pain Disorders in Europe, till 2035 (USD Billion)
Figure 14.38 Medical Device CROs Market for Ophthalmic Disorders in Europe, till 2035 (USD Billion)
Figure 14.39 Medical Device CROs Market for Psychological Disorders in Europe, till 2035 (USD Billion)
Figure 14.40 Medical Device CROs Market for Metabolic Disorders in Europe, till 2035 (USD Billion)
Figure 14.41 Medical Device CROs Market for Other Disorders in Europe, till 2035 (USD Billion)
Figure 14.42 Medical Device CROs Market for Class I Devices in Europe, till 2035 (USD Billion)
Figure 14.43 Medical Device CROs Market for Class II Devices in Europe, till 2035 (USD Billion)
Figure 14.44 Medical Device CROs Market for Class III Devices in Europe, till 2035 (USD Billion)
Figure 14.45 Medical Device CROs Market for Clinical Trial Management Services in Europe, till 2035 (USD Billion)
Figure 14.46 Medical Device CROs Market for Consulting Services in Europe, till 2035 (USD Billion)
Figure 14.47 Medical Device CROs Market for Data Management Services in Europe, till 2035 (USD Billion)
Figure 14.48 Medical Device CROs Market for Regulatory Affairs Management Services in Europe, till 2035 (USD Billion)
Figure 14.49 Medical Device CROs Market for Other Clinical Services in Europe, till 2035 (USD Billion)
Figure 14.50 Medical Device CROs Market for Material Characterization and Analytical Services in Europe, till 2035 (USD Billion)
Figure 14.51 Medical Device CROs Market for Biocompatibility Testing Services in Europe, till 2035 (USD Billion)
Figure 14.52 Medical Device CROs Market for Sterility and Microbiology Testing Services in Europe, till 2035 (USD Billion)
Figure 14.53 Medical Device CROs Market for Other Preclinical Services in Europe, till 2035 (USD Billion)
Figure 14.54 Medical Device CROs Market in Asia-Pacific, till 2035 (USD Billion)
Figure 14.55 Medical Device CROs Market for CNS Disorders in Asia-Pacific, till 2035 (USD Billion)
Figure 14.56 Medical Device CROs Market for Cardiovascular Disorders in Asia-Pacific, till 2035 (USD Billion)
Figure 14.57 Medical Device CROs Market for Oncological Disorders in Asia-Pacific, till 2035 (USD Billion)
Figure 14.58 Medical Device CROs Market for Bone Disorders in Asia-Pacific, till 2035 (USD Billion)
Figure 14.59 Medical Device CROs Market for Respiratory Disorders in Asia-Pacific, till 2035 (USD Billion)
Figure 14.60 Medical Device CROs Market for Pain Disorders in Asia-Pacific, till 2035 (USD Billion)
Figure 14.61 Medical Device CROs Market for Ophthalmic Disorders in Asia-Pacific, till 2035 (USD Billion)
Figure 14.62 Medical Device CROs Market for Psychological Disorders in Asia-Pacific, till 2035 (USD Billion)
Figure 14.63 Medical Device CROs Market for Metabolic Disorders in Asia-Pacific, till 2035 (USD Billion)
Figure 14.64 Medical Device CROs Market for Other Disorders in Asia-Pacific, till 2035 (USD Billion)
Figure 14.65 Medical Device CROs Market for Class I Devices in Asia-Pacific, till 2035 (USD Billion)
Figure 14.66 Medical Device CROs Market for Class II Devices in Asia-Pacific, till 2035 (USD Billion)
Figure 14.67 Medical Device CROs Market for Class III Devices in Asia-Pacific, till 2035 (USD Billion)
Figure 14.68 Medical Device CROs Market for Clinical Trial Management Services in Asia-Pacific, till 2035 (USD Billion)
Figure 14.69 Medical Device CROs Market for Consulting Services in Asia-Pacific, till 2035 (USD Billion)
Figure 14.70 Medical Device CROs Market for Data Management Services in Asia-Pacific, till 2035 (USD Billion)
Figure 14.71 Medical Device CROs Market for Regulatory Affairs Management Services in Asia-Pacific, till 2035 (USD Billion)
Figure 14.72 Medical Device CROs Market for Other Clinical Services in Asia-Pacific, till 2035 (USD Billion)
Figure 14.73 Medical Device CROs Market for Material Characterization and Analytical Services in Asia-Pacific, till 2035 (USD Billion)
Figure 14.74 Medical Device CROs Market for Biocompatibility Testing Services in Asia-Pacific, till 2035 (USD Billion)
Figure 14.75 Medical Device CROs Market for Sterility and Microbiology Testing Services in Asia-Pacific, till 2035 (USD Billion)
Figure 14.76 Medical Device CROs Market for Other Preclinical Services in Asia-Pacific, till 2035 (USD Billion)
Figure 14.77 Medical Device CROs Market in Rest of the World, till 2035 (USD Billion)
Figure 14.78 Medical Device CRO Market for CNS Disorders in Rest of the World, till 2035 (USD Billion)
Figure 14.79 Medical Device CROs Market for Cardiovascular Disorders in Rest of the World, till 2035 (USD Billion)
Figure 14.80 Medical Device CROs Market for Oncological Disorders in Rest of the World, till 2035 (USD Billion)
Figure 14.81 Medical Device CROs Market for Bone Disorders in Rest of the World, till 2035 (USD Billion)
Figure 14.82 Medical Device CROs Market for Respiratory Disorders in Rest of the World, till 2035 (USD Billion)
Figure 14.83 Medical Device CROs Market for Pain Disorders in Rest of the World, till 2035 (USD Billion)
Figure 14.84 Medical Device CROs Market for Ophthalmic Disorders in Rest of the World, till 2035 (USD Billion)
Figure 14.85 Medical Device CROs Market for Psychological Disorders in Rest of the World, till 2035 (USD Billion)
Figure 14.86 Medical Device CROs Market for Metabolic Disorders in Rest of the World, till 2035 (USD Billion)
Figure 14.87 Medical Device CROs Market for Other Disorders in Rest of the World, till 2035 (USD Billion)
Figure 14.88 Medical Device CROs Market for Class I Devices in Rest of the World, till 2035 (USD Billion)
Figure 14.89 Medical Device CROs Market for Class II Devices in Rest of the World, till 2035 (USD Billion)
Figure 14.90 Medical Device CROs Market for Class III Devices in Rest of the World, till 2035 (USD Billion)
Figure 14.91 Medical Device CROs Market for Clinical Trial Management Services in Rest of the World, till 2035 (USD Billion)
Figure 14.92 Medical Device CROs Market for Consulting Services in Rest of the World, till 2035 (USD Billion)
Figure 14.93 Medical Device CROs Market for Data Management Services in Rest of the World, till 2035 (USD Billion)
Figure 14.94 Medical Device CROs Market for Regulatory Affairs Management Services in Rest of the World, till 2035 (USD Billion)
Figure 14.95 Medical Device CROs Market for Other Clinical Services in Rest of the World, till 2035 (USD Billion)
Figure 14.96 Medical Device CROs Market for Material Characterization and Analytical Services in Rest of the World, till 2035 (USD Billion)
Figure 14.97 Medical Device CROs Market for Biocompatibility Testing Services in Rest of the World, till 2035 (USD Billion)
Figure 14.98 Medical Device CROs Market for Sterility and Microbiology Testing Services in Rest of the World, till 2035 (USD Billion)
Figure 14.99 Medical Device CROs Market for Other Preclinical Services in Rest of the World, till 2035 (USD Billion)
Figure 15.1 Medical Device CROs Market: SWOT Analysis
Figure 15.2 Comparison of SWOT Factors: Harvey Ball Analysis
Figure 16.1 Future Trends and Opportunities for Medical Device CROs
Figure 17.1 Concluding Remarks: Overall Market Landscape
Figure 17.2 Concluding Remarks: Competitive Benchmarking
Figure 17.3 Concluding Remarks: Brand Positioning Analysis
Figure 17.4 Concluding Remarks: Clinical Trial Analysis
Figure 17.5 Concluding Remarks: Merger and Acquisitions
Figure 17.6 Concluding Remarks: Market Sizing and Opportunity Analysis
Figure 17.7 Concluding Remarks: Market Sizing and Opportunity Analysis

LIST OF TABLES

Table 3.1 Comparison of Key Factors Considered by Medical Device Developers While Selecting a CRO Partner: Harvey Ball Analysis
Table 4.1 Medical Device CROs: List of Clinical Service Providers
Table 4.2 Medical Device Clinical CROs: Information on Device Class
Table 4.3 Medical Device Clinical CROs: Information on Type of Clinical Operation Service Offered
Table 4.4 Medical Device Clinical CROs: Information on Type of Regulatory Affairs- Related Service Offered
Table 4.5 Medical Device Clinical CROs: Information on Additional Service Offered
Table 4.6 Medical Device Clinical CROs: Information on Medical Device Regulatory Compliance Authorities
Table 4.7 Medical Device CROs: List of Preclinical Service Providers
Table 4.8 Medical Device Preclinical CROs: Information on Type of Preclinical Services Offered
Table 4.9 Medical Device CROs: List of Standalone Service Providers
Table 5.1 General Guidelines for Market Authorization and Reimbursement for Medical Devices
Table 5.2 Device Classification: US
Table 5.3 Device Classification: Canada
Table 5.4 Data Requirements and Characteristics of Province-wide HTA Processes in Canada
Table 5.5 Device Classification: Mexico
Table 5.6 Device Classification: Europe
Table 5.7 List of CE Directives in Europe
Table 5.8 Conformity Assessment Modules in Europe
Table 5.9 Device Classification: Australia
Table 5.10 Reimbursement and Pricing Approval Process of Medical devices in Australia
Table 5.11 Device Classification: Brazil
Table 5.12 Device Classification: China
Table 5.13 Device Classification: India
Table 5.14 Device Classification: Japan
Table 5.15 Medical Devices Reimbursement Categories
Table 5.16 Device Classification: New Zealand
Table 5.17 Device Classification: Singapore
Table 5.18 Device Classification: South Korea
Table 5.19 Device Classification: South Africa
Table 5.20 Device Classification: Thailand
Table 5.21 Medical Devices Regulatory Landscape Summary
Table 5.22 Medical Devices Reimbursement Landscape Summary
Table 6.1 Avania: Company Overview
Table 6.2 Avania: Recent Developments and Future Outlook
Table 6.3 Charles River Laboratories: Company Overview
Table 6.4 Charles River Laboratories: Recent Developments and Future Outlook
Table 6.5 CROMSOURCE: Company Overview
Table 6.6 CROMSOURCE: Recent Development and Future Outlook
Table 6.7 CSSi LifeSciences: Company Overview
Table 6.8 Eurofins Medical Device Testing: Company Overview
Table 6.9 Eurofins Medical Device Testing: Recent Development and Future Outlook
Table 6.10 IQVIA: Company Overview
Table 6.11 IQVIA: Recent Development and Future Outlook
Table 6.12 Medpace: Company Overview
Table 6.13 Medpace: Recent Development and Future Outlook
Table 6.14 NAMSA: Company Overview
Table 6.15 NAMSA: Recent Development and Future Outlook
Table 6.16 Qserve Group: Company Overview
Table 6.17 Qserve Group: Recent Development and Future Outlook
Table 6.18 WuXi AppTec: Company Overview
Table 6.19 WuXi AppTec: Recent Development and Future Outlook
Table 8.1 Competitive Benchmarking Analysis: Peer Groups Definitions and Inclusions
Table 11.1 Medical Device CRO Market: List of Mergers and Acquisitions, since 2015
Table 11.2 Acquisitions: Key Value Drivers
Table 12.1 Total Cost of Ownership: Sample Dataset
Table 13.1 Survey Insights: Overview of Respondents
Table 13.2 Survey Insights: Designation and Seniority Level of Respondents
Table 13.3 Survey Insights: Information on Type of Service Offered
Table 13.4 Survey Insights: Information on Target Therapeutic Area
Table 13.5 Survey Insights: Information on Average Number of Projects
Table 13.6 Survey Insights: Information on Market Opportunity
Table 14.1 Key Assumptions
Table 18.1 Medical Device Clinical CROs: Distribution by Year of Establishment
Table 18.2 Medical Device Clinical CROs: Distribution by Company Size
Table 18.3 Medical Device Clinical CROs: Distribution by Location of Headquarters
Table 18.4 Medical Device Clinical CROs: Distribution by Company Size and Location of Headquarters
Table 18.5 Medical Device Clinical CROs: Distribution by Area of Specialization
Table 18.6 Medical Device Clinical CROs: Distribution by Device Class
Table 18.7 Medical Device Clinical CROs: Distribution by Type of Clinical Operation Services Offered
Table 18.8 Medical Device Clinical CROs: Distribution by Distribution by Year of Establishment, Type of Clinical Services Offered, and Geography
Table 18.9 Medical Device Clinical CROs: Distribution by Type of Regulatory Affairs Related Services Offered
Table 18.10 Medical Device Clinical CROs: Distribution by Type of Additional Services Offered
Table 18.11 Medical Device Clinical CROs: Distribution by Type of Medical Device Regulatory Compliance Authorities
Table 18.12 Medical Device Preclinical CROs: Distribution by Year of Establishment
Table 18.13 Medical Device Preclinical CROs: Distribution by Company Size
Table 18.14 Medical Device Preclinical CROs: Distribution by Location of Headquarters
Table 18.15 Medical Device Preclinical CROs: Distribution by Company Size and Location of Headquarters
Table 18.16 Medical Device Preclinical CROs: Distribution by Type of Preclinical Services Offered
Table 18.17 Medical Device Preclinical CROs: Distribution by Year of Establishment, Type of Preclinical Services Offered, and Geography
Table 18.18 Medical Device Standalone CROs: Distribution by Year of Establishment
Table 18.19 Medical Device Standalone CROs: Distribution by Company Size
Table 18.20 Medical Device Standalone CROs: Distribution by Location of Headquarters
Table 18.21 Medical Device Standalone CROs: Distribution by Company Size and Location of Headquarters
Table 18.22 Competitive Benchmarking: Distribution by Region and Company Size
Table 18.23 Competitive Benchmarking: Small Players based in North America (Peer Group I)
Table 18.24 Competitive Benchmarking: Mid-sized Players based in North America (Peer Group II)
Table 18.25 Competitive Benchmarking: Large Players based in North America (Peer Group III)
Table 18.26 Competitive Benchmarking: Small Players based in Europe (Peer Group IV)
Table 18.27 Competitive Benchmarking: Mid-sized Players based in Europe (Peer Group V)
Table 18.28 Competitive Benchmarking: Large Players based in Europe (Peer Group VI)
Table 18.29 Competitive Benchmarking: Small Players based in Asia-Pacific (Peer Group VII)
Table 18.30 Competitive Benchmarking: Mid-sized Players based in Asia-Pacific (Peer Group VIII)
Table 18.31 Competitive Benchmarking: Large Players based in Asia-Pacific (Peer Group IX)
Table 18.32 Competitive Benchmarking: Small Players based in Rest of the World (Peer Group X)
Table 18.33 Competitive Benchmarking: Mid-sized Players based in Rest of the World (Peer Group XI)
Table 18.34 Brand Positioning of Key Industry Players: Unfair Advantage
Table 18.35 Brand Positioning of Key Industry Players: Reasons to Believe
Table 18.36 Brand Positioning Matrix: Labcorp
Table 18.37 Brand Positioning Matrix: IQVIA
Table 18.38 Brand Positioning Matrix: Syneos Health
Table 18.39 Brand Positioning Matrix: PPD
Table 18.40 Brand Positioning Matrix: ICON
Table 18.41 Brand Positioning Matrix: Charles River Laboratories
Table 18.42 Brand Positioning Matrix: WuXi AppTec
Table 18.43 Brand Positioning Matrix: Medpace
Table 18.44 Clinical Trial Analysis: Distribution by Trial Registration Year, since 2015
Table 18.45 Clinical Trial Analysis: Distribution by Trial Status
Table 18.46 Clinical Trial Analysis: Distribution by Phase of Development
Table 18.47 Clinical Trial Analysis: Distribution by Study Design
Table 18.48 Clinical Trial Analysis: Distribution by Therapeutic Area
Table 18.49 Clinical Trial Analysis: Distribution by Geography
Table 18.50 Clinical Trial Analysis: Distribution by Trial Registration Year and Geography
Table 18.51 Clinical Trial Analysis: Distribution by Trial Status and Geography
Table 18.52 Clinical Trial Analysis: Distribution by Type of Sponsor
Table 18.53 Most Active Players: Distribution by Number of clinical Trials
Table 18.54 Clinical Trial Analysis: Distribution of Enrolled Patient Population by Trial Registration Year
Table 18.55 Clinical Trial Analysis: Distribution of Enrolled Patient Population by Phase of Development
Table 18.56 Clinical Trial Analysis: Distribution of Enrolled Patient Population by Geography
Table 18.57 Clinical Trial Analysis: Distribution of Enrolled Patient Population Trial Status and Geography
Table 18.58 Mergers and Acquisitions: Cumulative Year-Wise Trend (since 2015)
Table 18.59 Mergers and Acquisitions: Distribution by Type of Agreement
Table 18.60 Mergers and Acquisitions: Distribution by Year and Type of Agreement
Table 18.61 Mergers and Acquisitions: Continent-wise Distribution
Table 18.62 Mergers and Acquisitions: Intercontinental and Intracontinental Acquisitions
Table 18.63 Mergers and Acquisitions: Country-wise Distribution
Table 18.64 Mergers and Acquisitions: Ownership Change Matrix
Table 18.65 Mergers and Acquisitions: Distribution by Type of Company
Table 18.66 Mergers and Acquisitions: Distribution by Key Value Drivers
Table 18.67 Mergers and Acquisitions: Distribution by Key Value Drivers and Year of Acquisition
Table 18.68 Total Cost of Ownership for Large Medical Device Contract Research Organizations, Y0-Y20 (USD Million)
Table 18.69 Total Cost of Ownership for Large Medical Device Contract Research Organizations, Y0: Distribution of CAPEX (USD Million)
Table 18.70 Total Cost of Ownership for Large Medical Device Contract Research Organizations, Y1-Y20: Distribution by OPEX (USD Million)
Table 18.71 Survey Insights: Distribution of Respondents by Designation and Seniority Level
Table 18.72 Survey Insights: Distribution of Respondents by Type of Service Offered
Table 18.73 Survey Insights: Distribution of Respondents by Therapeutic Area
Table 18.74 Survey Insights: Distribution of Respondents by Average Number of Projects
Table 18.75 Survey Insights: Distribution of Respondents by Market Opportunity
Table 18.76 Overall Medical Device CROs Market, till 2035: Conservative, Base and Optimistic Scenario (USD Billion)
Table 18.77 Medical Device CRO Market: Distribution by Therapeutic Area, till 2035 (USD Billion)
Table 18.78 Medical Device CROs Market: Distribution by Scale of Operation, till 2035 (USD Billion)
Table 18.79 Medical Device CROs Market: Distribution by Device Class, till 2035 (USD Billion)
Table 18.80 Medical Device CROs Market: Distribution by Type of Clinical Service Offered, till 2035 (USD Billion)
Table 18.84 Medical Device CROs Market: Distribution by Type of Preclinical Service Offered, till 2035 (USD Billion)
Table 18.85 Medical Device CROs Market: Distribution by Geography, 2022, 2028 and 2035 (USD Billion)
Table 18.86 Medical Device CROs Market in North America, till 2035: Conservative, Base and Optimistic Scenario (USD Billion)
Table 18.87 Medical Device CRO Market in North America, till 2035: Distribution by Therapeutic Area, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 18.88 Medical Device CRO Market in North America, till 2035: Distribution by Device Class, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 18.89 Medical Device CRO Market in North America, till 2035: Distribution by Type of Clinical Service Offered, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 18.90 Medical Device CRO Market in North America, till 2035: Distribution by Type of Preclinical Service Offered, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 18.91 Medical Device CROs Market in Europe, till 2035: Conservative, Base and Optimistic Scenario (USD Billion)
Table 18.92 Medical Device CRO Market in Europe, till 2035: Distribution by Therapeutic Area, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 18.93 Medical Device CRO Market in Europe, till 2035: Distribution by Device Class, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 18.94 Medical Device CRO Market in Europe, till 2035: Distribution by Type of Clinical Service Offered, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 18.95 Medical Device CRO Market in Europe, till 2035: Distribution by Type of Preclinical Service Offered, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 18.96 Medical Device CROs Market in Asia-Pacific, till 2035: Conservative, Base and Optimistic Scenario (USD Billion)
Table 18.97 Medical Device CRO Market in Asia-Pacific, till 2035: Distribution by Therapeutic Area, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 18.98 Medical Device CRO Market in Asia-Pacific, till 2035: Distribution by Device Class, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 18.99 Medical Device CRO Market in Asia-Pacific, till 2035: Distribution by Type of Clinical Service Offered, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 18.99 Medical Device CRO Market in Asia-Pacific, till 2035: Distribution by Type of Preclinical Service Offered, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 18.100 Medical Device CROs Market in North America, till 2035: Conservative, Base and Optimistic Scenario (USD Billion)
Table 18.101 Medical Device CRO Market in Rest of the World, till 2035: Distribution by Therapeutic Area, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 18.102 Medical Device CRO Market in Rest of the World, till 2035: Distribution by Device Class, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 18.103 Medical Device CRO Market in Rest of the World, till 2035: Distribution by Type of Clinical Service Offered, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 18.104 Medical Device CRO Market in Rest of the World, till 2035: Distribution by Type of Preclinical Service Offered, Conservative, Base and Optimistic Scenarios (USD Billion)

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Labcorp
IQVIA
Syneos Health
PPD
ICON
Charles River Laboratories
WuXi AppTec
Medpace
NAMSA

Methodology

LOADING...

License	Format	Properties	Price
SINGLE USER LICENSE PDF and Excel	The electronic report will be emailed to you. The file formats are PDF and Excel.	This is a single user license, allowing one user access to the product.	€4758EUR$4,799USD£3,989GBP
SITE LICENSE PDF and Excel	The electronic report will be emailed to you. The file formats are PDF and Excel.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€6940EUR$6,999USD£5,818GBP
ENTERPRISE LICENSE PDF and Excel	The electronic report will be emailed to you. The file formats are PDF and Excel.	This is an enterprise license, allowing all employees within your organization access to the product.	€17846EUR$17,999USD£14,962GBP

Medical Device CRO Market: Growth and Trends

Medical Device CRO Market: Key Insights

Medical Device CRO Market: Key Segments

Currently, Clinical Operations Segment Occupies the Largest Share of the Medical Device CRO Market

Class II Devices Segment is the Fastest Growing Segment of the Medical Device CRO Market During the Forecast Period

Currently, Clinical Trial Management Segment Occupies the Largest Share of the Medical Device CRO Market

Biocompatibility Testing Services Segment is the Fastest Growing Segment of the Medical Device CRO Market During the Forecast Period

Currently, CNS Disorders Segment Occupies the Largest Share of the Medical Device CRO Market

North America Accounts for the Largest Share of the Market

Primary Research Overview

Medical Device CRO Market: Research Coverage

Key Questions Answered in this Report

Reasons to Buy this Report

Additional Benefits

Table of Contents

Companies Mentioned (Partial List)

Methodology

Related Topics

Related Reports

Cell and Gene Therapy CRO Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Cell Therapy, Type of Genetic Modification, Stage of Development, Therapeutic Area, End-users and Key Geographical Regions

Contract Research Outsourcing - Global Strategic Business Report

Human Factors and Usability Engineering Services Market Industry Trends and Global Forecasts to 2035: Distribution by Steps Involved, Type of Research Method, Class of Medical Device Tested, Geographical Region and Leading Players

Medical Device Contract Research Organization (CRO) Market Report 2024

Preclinical CRO Market by Services, Application, End-User - Global Forecast 2025-2030